Farther Finance Advisors’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536 | Buy |
149
+3
| +2% | +$11 | ﹤0.01% | 4020 |
|
|
2025
Q1 | $416 | Sell |
146
-70
| -32% | -$199 | ﹤0.01% | 3805 |
|
|
2024
Q4 | $724 | Hold |
216
| – | – | ﹤0.01% | 3348 |
|
|
2024
Q3 | $724 | Sell |
216
-17
| -7% | -$57 | ﹤0.01% | 3329 |
|
|
2024
Q2 | $785 | Sell |
233
-68
| -23% | -$229 | ﹤0.01% | 3150 |
|
|
2024
Q1 | $1.2K | Buy |
301
+85
| +39% | +$340 | ﹤0.01% | 2699 |
|
|
2023
Q4 | $659 | Buy |
216
+78
| +57% | +$238 | ﹤0.01% | 2880 |
|
|
2023
Q3 | $414 | Hold |
138
| – | – | ﹤0.01% | 2317 |
|
|
2023
Q2 | $516 | Hold |
138
| – | – | ﹤0.01% | 2145 |
|
|
2023
Q1 | $462 | Sell |
138
-158
| -53% | -$529 | ﹤0.01% | 2023 |
|
|
2022
Q4 | $1.42K | Buy |
+296
| New | +$1.42K | ﹤0.01% | 1558 |
|